Múltipla aplicação de células mononucleares da medula óssea melhora a locomoção de ratos com lesão medular independente de expressão de citocinas inflamatórias

• Autor(a) principal: Bonatto, Francine Aurora
• Data de Publicação: 2013
• Tipo de documento: Dissertação
• Idioma: por
• Título da fonte: Biblioteca Digital de Teses e Dissertações da PUC_RS
• Texto Completo: http://tede2.pucrs.br/tede2/handle/tede/1740
• topic: MEDICINA; MEDULA ÓSSEA; CÉLULAS-TRONCO; RATOS - EXPERIÊNCIAS; CNPQ::CIENCIAS DA SAUDE::MEDICINA

The spinal cord injury (SCI) is a condition that dramatically affects the quality of life of affected patients, has a high incidence and causes a high cost to the government and society. Existing treatments for SCI are only palliative nature, not being able to reverse the neurological damage caused by trauma. As a result, it is necessary to investigate new therapies that seek more effective solutions for these cases. The studies with bone marrow mononuclear cells (BMMC) have shown encouraging results, but still not definitive for clinical application, so the expansion of preclinical studies is essential. In this study we aimed to compare treatment outcomes between groups with 3 and 5 applications BMMC applications, analyzing motor function, and inflammation at the lesion site after treatment with BMMC by subarachnoid through via lumbar puncture. The experimental groups were divided into two groups, with different times of transplantation. A group of 3 applications of BMMC, the first application 48 hours, 9 days and 16 days after SCI and a second group with 5 BMMC applications, application in the first 48 hours, 9, 16, 23 and 30 days after by spinal cord injury. The BMMC of male wistar rats was applied via subarachnoid. The entire group received vehicle (saline). The animals were evaluated for motor function through the BBB scale, for the presence of BMMC in the lesion by PCR for the presence of Y chromossome of the cells, and the inflammatory process at the site of injury, analyzing IL-1β and TNF-α, by immunohistochemistry. Our results show an improvement in motor function in the groups treated with BMMC transplants. The immunohistochemical evaluation revealed no difference in the expression of inflammatory cytokines Il-1β and TNF-α at the site of injury in the groups treated with BMMC. The PCR analysis for the presence of chromossome of the cells was negative at the 37th day of the last application of BMMCs